Posted on 4/10/19

Teva's Returning To EPS Growth In 2020 Looks Solid

SummaryTeva remains the largest manufacturer of generic drugs in the world, and recent fat cutting efforts have increased its scale efficiency.Collapsing margins should be near the . . .